Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-1996 | 12-1995 | 09-1995 | 06-1995 | 03-1995 | |
| Operating Expenses | 2,910 | 0 | 3,330 | 3,390 | 3,190 |
| Operating Income | -2,910 | N/A | -3,330 | -3,390 | -3,190 |
| Pre-tax Income | -2,910 | 0 | -3,330 | -3,390 | -3,190 |
| Net Income Continuous | -2,910 | N/A | -3,330 | -3,390 | -3,190 |
| Net Income | $-2,910 | $N/A | $-3,330 | $-3,390 | $-3,190 |
| EBITDA(a) | $-1,290 | $N/A | $-3,330 | $-3,390 | $-3,190 |